Filing Details

Accession Number:
0001209191-11-040998
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-26 17:54:01
Reporting Period:
2011-07-25
Filing Date:
2011-07-26
Accepted Time:
2011-07-26 17:54:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107332 Dendreon Corp DNDN Pharmaceutical Preparations (2834) 223203193
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242882 Mitchell Gold 3005 First Avenue
Seattle WA 98121
President & Chief Executive Of No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-07-25 15,119 $38.37 229,666 No 4 S Direct
Common Stock Disposition 2011-07-25 3,881 $38.37 225,785 No 4 S Direct
Common Stock Acquisiton 2011-07-25 3,881 $4.90 229,666 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option(right to buy) Disposition 2011-07-25 3,881 $38.37 3,881 $4.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,507 2017-12-05 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
  2. These options vest as follows: 25% on the first year anniversay and 1/36th thereafter